Evidence map›Paper›PMID 21595947›Full record

ArticleBMC immunology2011

Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor.

Elizabeth P Smith, Kathleen Shanks, Michael M Lipsky, Louis J DeTolla, Achsah D Keegan, Svetlana P Chapoval

Open access · goldAbstract read
In one paragraph

Article in BMC immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Identifying Function Determining Residues in Neuroimmune Semaphorin 4A.International journal of molecular sciences · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Effects of CD100 promote wound healing in diabetic mice.Journal of molecular histology · 2018
    Article
  12. Neuroimmune semaphorins as costimulatory molecules and beyond.Molecular medicine (Cambridge, Mass.) · 2018
    Review
  13. CD100/Sema4D Increases Macrophage Infection byFrontiers in microbiology · 2018
    Article
  14. CD100 Effects in Macrophages and Its Roles in Atherosclerosis.Frontiers in cardiovascular medicine · 2018
    Review
  15. Review
  16. Article
  17. Semaphorins 4A and 4D in chronic inflammatory diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Elizabeth P SmithCenter for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Kathleen Shanks
Michael M Lipsky
Louis J DeTolla
Achsah D Keegan
Svetlana P Chapoval
University of Maryland, Baltimore · US

Funding

Molecular Mechanisms of IL-4 and IL-13 SignalingR01AI038985 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI KEEGAN, ACHSAH D. · 2001 to 2010
$3.7M
Regulation of Myeloid Development and Function by II-4R01AI059775 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI KEEGAN, ACHSAH D. · 2005 to 2010
$1.7M
Immune Semaphorins in Allergic Airway InflammationR21AI076736 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI CHAPOVAL, SVETLANA P. · 2009 to 2010
$413k
NIAID NIH HHS R01AI038985NIAID NIH HHS R01AI59775NIAID NIH HHS R21 AI076736NIAID NIH HHS R21AI076736
6 · The paper itself

Abstract

backgroundSemaphorins were originally identified as molecules regulating a functional activity of axons in the nervous system. Sema4A and Sema4D were the first semaphorins found to be expressed on immune cells and were termed "immune semaphorins". It is known that Sema4A and Sema4D bind Tim-2 and CD72 expressed on leukocytes and PlexinD1 and B1 present on non-immune cells. These neuroimmune semaphorins and their receptors have been shown to play critical roles in many physiological and pathological processes including neuronal development, immune response regulation, cancer, autoimmune, cardiovascular, renal, and infectious diseases. However, the expression and regulation of Sema4A, Sema4D, and their receptors in normal and allergic lungs is undefined.

resultsAllergen treatment and lung-specific vascular endothelial growth factor (VEGF) expression induced asthma-like pathologies in the murine lungs. These experimental models of allergic airway inflammation were used for the expression analysis of immune semaphorins and their receptors employing immunohistochemistry and flow cytometry techniques. We found that besides accessory-like cells, Sema4A was also detected on bronchial epithelial and smooth muscle cells, whereas Sema4D expression was high on immune cells such as T and B lymphocytes. Surprisingly, under inflammation various cell types including macrophages, lymphocytes, and granulocytes in the lung expressed Tim-2, a previously defined marker for Th2 cells. CD72 was found on lung immune, inflammatory, and epithelial cells. Bronchial epithelial cells were positive for both plexins, whereas some endothelial cells selectively expressed Plexin D1. Plexin B1 expression was also detected on lung DC. Both allergen and VEGF upregulated the expression of neuroimmune semaphorins and their receptors in the lung tissue. However, the lung tissue Sema4A-Tim2 expression was rather weak, whereas Sema4D-CD72 ligand-receptor pair was vastly upregulated by allergen. Soluble Sema4D protein was present in the lung lysates and a whole Sema4A protein plus its dimer were readily detected in the bronchoalveolar (BAL) fluids under inflammation.

conclusionsThis study clearly shows that neuroimmune semaphorins Sema4A and Sema4D and their receptors might serve as potential markers for the allergic airway inflammatory diseases. Our current findings pave the way for further investigations of the role of immune semaphorins in inflammation and their use as potential therapeutic targets for the inflammatory lung conditions.

Indexed as

AllergensAnimalsAntigens, CDAntigens, Differentiation, B-LymphocyteAsthmaB-LymphocytesCell Adhesion MoleculesHumansImmunohistochemistryLungMembrane ProteinsMiceMice, Inbred C57BLNerve Tissue ProteinsOvalbuminPneumoniaAllergensAntigens, CDAntigens, Differentiation, B-LymphocyteCD72 antigen, mouseCell Adhesion MoleculesMembrane ProteinsNerve Tissue ProteinsOvalbuminplexinSemaphorinsTimd2 protein, mouseVascular Endothelial Growth Factor A

Identifiers

PMID21595947
PMCPMC3118960
OpenAlexW2100776048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.